Wird aktualisiert
Aktuelle Folge
Mesenchymal stromal cells: a potential new SLE treatment option?

Mesenchymal stromal cells: a potential new SLE treatment option?

Duane Peters from the Lup...
Länge: 17:58
Duane Peters from the Lupus Foundation of America interviews Dr Gary Gilkeson from the Medical University of South Carolina about a phase I trial into the use of mesenchymal stromal cells (MSC) in refractory lupus patients in the USA, following impressive results of clinical improvement resulting from this therapy in China.
The trial indicated that infusions of MSCs derived from the umbilical cord are safe and may be effective in treating mild to moderate systemic lupus erythematosus, with minimal adverse effects.
Access the article: http://dx.doi.org/10.1136/lupus-2022-000704
Folgen-ID: 1000574862649
GUID: https://soundcloud.com/bmjpodcasts/mesenchymal-stromal-cells-a-potential-new-sle-treatment-option
Erscheinungs­datum: 2.8.2022, 12:26:21


Lupus Science and Medicine is a global, peer reviewed, Open Access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific Open Access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.


Kein Eintrag